

OncoOne, an Austrian biotech startup focused on treating patients with solid tumors, has secured 13 million euros in Series A funding. The investors included Austrian Research Promotion Agency, the Austria Wirtschaftsservice Gesellschaft and two family offices.
Source: Press Release